- Polymyxin - Wikipedia
Polymyxins are antibiotics Polymyxins B and E (also known as colistin) are used in the treatment of Gram-negative bacterial infections They work mostly by breaking up the bacterial cell membrane They are part of a broader class of molecules called nonribosomal peptides
- Polymyxin B Trimethoprim (Polytrim) ophthalmic: Uses, Side . . . - WebMD
Find patient medical information for Polymyxin B Trimethoprim (Polytrim) ophthalmic on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
- Polymyxin B: Indications, Side Effects, Warnings - Drugs. com
Easy-to-read patient leaflet for Polymyxin B Includes indications, proper use, special instructions, precautions, and possible side effects
- Polymyxin B (Polymyxin B Sulfate): Side Effects, Uses, Dosage . . . - RxList
Polymyxin B (polymyxin b sulfate) is an antibiotic used to treat bacterial infections such as urinary tract infections, meningitis, blood infections, and eye infections Polymyxin B is available in generic form Common side effects of Polymyxin B include: temporary blurred vision if used as eye drops
- Polymyxins: An overview - UpToDate
Polymyxins are bactericidal drugs that bind to lipopolysaccharides (LPS) and phospholipids in the outer cell membrane of gram-negative bacteria
- Recent Advances in the Development of Polymyxin Antibiotics: 2010–2023
The polymyxins are nonribosomal lipopeptides produced by Paenibacillus polymyxa and are potent antibiotics with activity specifically directed against Gram-negative bacteria
- Polymyxin | Antibiotic, Bacterial Infections, Gram-Negative | Britannica
Polymyxin, any of five polypeptide antibiotics derived from various species of soil bacterium in the genus Bacillus that are active against gram-negative bacteria such as Escherichia coli and Pseudomonas aeruginosa
- Polymyxins: recent advances and challenges - PubMed
Antibiotic resistance is a pressing global health challenge, and polymyxins have emerged as the last line of defense against multidrug-resistant Gram-negative (MDR-GRN) bacterial infections
|